Monsanto Company (MON) - NYSE
  • Tue, May 10, 11:27 AM
    • Monsanto (MON +0.1%) cuts its forecast for 2016 U.S. plantings of its newly launched Roundup Ready 2 Xtend soybeans, citing the European Union's lack of approval so far for the genetically modified trait.
    • MON says it now expects less than 2M U.S. acres to be planted with Roundup Ready 2 Xtend, down from earlier forecasts for 3M acres.
    • MON says it remains on track to reach 35M acres for Intacta RR2 PRO soybeans in South America in FY 2016 on the way to eventually reach 100M acres.
    | Tue, May 10, 11:27 AM
  • Mon, May 2, 6:53 PM
    • U.S. grain companies plan to reject Monsanto's (NYSE:MON) new genetically modified soybeans due to concerns that they could disrupt international trade without a key regulatory approval from the European Union, Dow Jones reports.
    • Trade groups representing Cargill, Archer Daniels Midland (NYSE:ADM), Bunge (NYSE:BG) and other grain companies criticized MON's decision to sell the seeds before first securing an approval required to ship the crops to the EU, according to a letter reviewed by WSJ.
    • The grain companies' stance is a potential blow to MON's new Roundup Ready 2 Xtend soybean seeds that MON has touted as a blockbuster for U.S. farm fields with hopes of selling ~3M acres' worth of the product to U.S. farmers this spring.
    • Now read Monsanto, scientists claim breakthrough in battle against GMO crop pests
    | Mon, May 2, 6:53 PM | 6 Comments
  • Wed, Apr. 27, 6:28 PM
    • Scientists from Monsanto (NYSE:MON) and Harvard claim a breakthrough in the battle against pests that can resist genetically modified crops designed to kill them.
    • A new technology allowing for rapid changes to bug-killing proteins could provide a new way to tweak biotech crops such as corn and cotton to boost resistance to pests, according to a new study published by the scientists.
    • The technology is said to be years away from being deployed in farm fields, and it is unclear if such pest-resistant crops would require new regulatory reviews, but if successfully deployed, it has the potential restore the value of GMO crops that have become less effective in recent years as insect resistance has spread.
    | Wed, Apr. 27, 6:28 PM | 12 Comments
  • Wed, Apr. 20, 9:59 AM
    • Monsanto (MON -0.2%) has rejected a request by Argentina for more time to force farmers to pay royalties on genetically modified soybean seeds, Bloomberg reports.
    • The decision follows a government resolution that gives its agriculture ministry control of the analysis of seeds in the country, a move that would render obsolete a MON-funded network of laboratories set up to detect its seeds at Argentine ports and help enforce payment.
    • MON and the government agree that large soybean growers must pay royalties, but the sticking point is over how to deal with growers who use MON technology but who do not buy the seeds directly from the company.
    • Now read Vermont seeks documents on GMOs from seed, food companies
    | Wed, Apr. 20, 9:59 AM | 2 Comments
  • Fri, Apr. 15, 4:57 PM
    • Vermont’s attorney general asks a federal court to force Monsanto (NYSE:MON), DuPont (NYSE:DD), Syngenta (NYSE:SYT) and other big seed and food companies to turn over internal research related to “potential health or environmental impacts” of GMO crops, as well as pesticides used on them.
    • The AG also is seeking from ConAgra (NYSE:CAG) and Kellogg's (NYSE:K) “consumer survey research” conducted over the past decade on GMO foods and on the use of “natural” labels on such products.
    • Vermont is defending its law passed in 2014 that requires labels for some food products made from biotech crops.
    | Fri, Apr. 15, 4:57 PM | 27 Comments
  • Thu, Apr. 14, 5:58 PM
    • Monsanto (NYSE:MON) would prefer voluntary federal labeling standards for GMOs to a patchwork of state regulations that would raise food costs and disrupt trade, the company's global corporate engagement lead tells Bloomberg.
    • "A federal standard [would bring] certainty for consumers and certainty for food companies," Jesus Madrazo says. "We need to strive for a reasonable approach that provides consumers what they need, but also doesn’t increase the cost of food or disruption on trade."
    • MON says it supports a voluntary labeling standard, similar to the organic seal, that would allow food companies the choice to label and do so in a fair way that does not imply a product labeled GMO is “less safe, or inferior, to its conventional or organic counterpart."
    | Thu, Apr. 14, 5:58 PM | 14 Comments
  • Wed, Apr. 13, 10:57 AM
    • Monsanto's (MON +1.1%) board approves a $975M capital investment to expand its dicamba formulation pipeline in Luling, La.
    • MON says the expansion will support the launch of its Roundup Ready Xtend Crop System, and is expected to supply 25%-35% of the fully mature demand of the dicamba product, a key Roundup Ready Xtend component.
    • MON plans to launch Roundup Ready Xtend in the U.S., Brazil, Latin America and other areas over the next decade.
    | Wed, Apr. 13, 10:57 AM | 2 Comments
  • Tue, Apr. 12, 4:46 PM
    • Germany plans to back an EU proposal that would allow the continued use of glyphosate in weedkillers, Reuters reports, citing a letter from the country's agriculture ministry.
    • Glyphosate is used in many herbicides including Monsanto's (NYSE:MON) Roundup, but has provoked a dispute between EU and UN agencies over whether it might cause cancers.
    • The EU last month delayed a decision on whether to approve a European Commission proposal to extend the authorization of glyphosate for 15 years until 2031; the existing authorization is due to lapse in June.
    • Now read Monsanto: Number one takeaway from Q2 results
    | Tue, Apr. 12, 4:46 PM | 1 Comment
  • Thu, Apr. 7, 8:26 AM
    • Monsanto (NYSE:MON) and Danish enzyme maker Novozymes (OTCPK:NVZMF) are joining forces in attempting to unlock the potential from the latest trend in farming: using nature’s own organisms to boost crop yields and reduce the use of fertilizers.
    • MON's move into microbes research is helping identify which organisms can work on specific crops, where and to what extent, with the aim of helping the industry optimize output; it could alter the economics of big ag companies, if the microbes help increase yields in industrial crops, and they can be used without chemical fertilizers, explains MarketWatch's Sara Sjolin.
    • "It’s about yields and how do we get the yields higher... this is another effort to drive yields to increase the productivity of food and manage the sustainability of our planet," says MON President and COO Brett Begemann.
    • Profit and crop yields aside, MON has for years struggled with negative publicity for its genetically modified products, and the push into microbes could help rejuvenate its reputation.
    • Now read Monsanto no longer sees 'large scale' M&A as a strategy, CEO says
    | Thu, Apr. 7, 8:26 AM | 5 Comments
  • Wed, Apr. 6, 12:23 PM
    • Monsanto (MON +0.6%) pokes into the green after CEO Hugh Grant says it does not see "large-scale" acquisitions as a strategy, and instead will focus on R&D and commercial partnerships to bolster growth.
    • "We no longer see large-scale M&A as a likely opportunity. Our strategy is not and was not dependent on large-scale M&A," CEO Hugh Grant said in the earnings conference call after reporting below consensus FQ2 earnings.
    • Grant said MON now sees "partnerships and collaborations” as a more likely path to expand its presence in crop chemicals.
    • The comments appear to signal the end of any lingering ambition to make another bid for a major crop chemicals or seeds business, after MON reportedly had been exploring potential deals with BASF and Bayer following last year's rejection of its $43.6B proposal to acquire Syngenta.
    • Now read Monsanto indicates lower as FQ2 results miss expectations
    | Wed, Apr. 6, 12:23 PM | 2 Comments
  • Wed, Apr. 6, 8:58 AM
    • Monsanto (NYSE:MON) -1.6% premarket after reporting weaker than expected FQ2 earnings and revenues, hurt by steep discounting on its seeds and a stronger dollar.
    • MON says revenue from seeds and genomics, its biggest business, fell 8.6% Y/Y in the quarter as sales of most seed types fell, while revenues in its agricultural productivity segment tumbled 30% to $715M; total sales fell 12.8% to $4.53B from $5.2B a year earlier.
    • MON reiterates its full-year EPS forecast of $4.40-$5.10, which was lowered last month from a prior outlook for $5.10-$5.60.
    • MON says it continues to expect relatively flat Y/Y growth in gross profit from its core seeds and genomics segment in FY 2016; excluding currency headwinds of nearly $400M, MON estimates seeds and genomics gross profit to rise by single digits, driven primarily by the expected increase in potential licensing deals, increased Intacta RR2 PRO soybean adoption and global corn market expansion.
    • Now read Monsanto's Plan B: Buy Bayer Cropscience?
    | Wed, Apr. 6, 8:58 AM
  • Wed, Apr. 6, 8:04 AM
    • Monsanto (NYSE:MON): FQ2 EPS of $2.42 misses by $0.02.
    • Revenue of $4.5B (-13.5% Y/Y) misses by $260M.
    • Press Release
    | Wed, Apr. 6, 8:04 AM
  • Tue, Apr. 5, 5:30 PM
  • Mon, Mar. 21, 12:59 PM
    • Bayer (OTCPK:BAYRY +3.2%) rose more than 3% in Germany today following reports late Friday that Monsanto (MON -1.3%) was interested in its crop science unit, and that the companies discussed possible asset purchases or joint ventures.
    • While acknowledging the need for consolidation in the sector, analysts tell WSJ they are skeptical about whether Bayer would be willing to part with the unit; Citi analysts think Bayer’s preferred option would be to retain CropScience, since it wants to transform into a pure life science company, and Equinet analysts also are skeptical about a possible deal unless a buyer offered a substantial premium.
    • The reported possible price tag of $30B, or €26.6B, would be 2.6x the unit’s estimated 2016 sales, far below the current sales multiple average of 3.3x for similar assets, according to Warburg Research analysts.
    | Mon, Mar. 21, 12:59 PM | 1 Comment
  • Fri, Mar. 18, 7:28 PM
    • Reuters reports Monsanto (NYSE:MON) has shown interest in Bayer's (OTCPK:BAYRY) crop science unit, including for a potential $30B+ acquisition. The news service cautions initial talks were preliminary; sources state another meeting is set for April.
    • Monsanto reportedly sees "valuable synergies" between its seed business and Bayer's crop-protection assets. An acquisition, a JV, or some other type of partnership are the possibilities that have been discussed.
    • Bayer's crop science business had 2015 revenue of $11.7B and adjusted EBITDA of $2.72B. Bayer has an estimated 18% crop chemical market share (#2 overall). Syngenta, which spurned Monsanto's buyout overtures last year and later agreed to sell to ChemChina for $43B, leads the market at 19%.
    | Fri, Mar. 18, 7:28 PM | 12 Comments
  • Wed, Mar. 16, 12:27 PM
    • Monsanto (MON +1.1%) is welcome to leave India if it does not want to lower prices of GMO cotton seeds as directed by the government, a minister tells Reuters, as the rift between the company and the government appears to escalate.
    • Under pressure to mollify farmers hit by three straight crop failures due to bad weather, Prime Minister Modi's government has imposed a ~70% cut in royalties that local firms pay MON for its cotton technology.
    • A junior ag minister says India is "not scared" if MON leaves, since the country's scientists are working to develop an indigenous variety of seeds.
    • MON declines comment on the remarks, but analysts believe it is unlikely to withdraw from India lightly given the huge size of the market and its strategic importance now that China has bid to snap up Syngenta, the company's biggest rival.
    | Wed, Mar. 16, 12:27 PM | 6 Comments
Company Description
Monsanto Co. provides agricultural products for farmers. Its seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity and produce better foods for consumers and better feed for animals. Monsanto operates its business through the following... More
Industry: Agricultural Chemicals
Country: United States